The FDA granted emergency authorization to the single-use test kit from Lucira Health, a California manufacturer. The vast majority require a nasal swab performed by a health professional and must be processed at laboratories using high-tech equipment. Rapid test results are critical to quickly quarantining those who are infected and tracing their contacts. Rapid test results are critical to quickly quarantining those who are infected and tracing their contacts. The Lucira test grew out of research the company was doing to develop an at-home flu test, according to the company’s website.

Source: The Standard November 18, 2020 07:52 UTC